World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
MRVIMaravai Lifesciences Holdings | $2.73bn | n/a | n/a |
DYNDyne Therapeutics | $2.73bn | n/a | n/a |
BLTEBelite Bio | $2.72bn | n/a | n/a |
MLTXMoonLake Immunotherapeutics | $2.61bn | n/a | n/a |
TGTXTG Therapeutics | $2.58bn | 75.79 | n/a |
ACADAcadia Pharmaceuticals | $2.51bn | n/a | n/a |
BIONBB Biotech AG | CH₣2.27bn | 7.37 | 4.83% |
CLDXCelldex Therapeutics | $2.43bn | n/a | n/a |
ARVNArvinas | $2.41bn | n/a | n/a |
NTLAIntellia Therapeutics | $2.40bn | n/a | n/a |
SMMTSummit Therapeutics | $2.37bn | n/a | n/a |
JANXJanux Therapeutics | $2.35bn | n/a | n/a |
FTREFortrea Holdings | $2.28bn | n/a | n/a |
DICEDice Therapeutics | $2.27bn | n/a | n/a |
RYTMRhythm Pharmaceuticals | $2.24bn | n/a | n/a |
DCPHDeciphera Pharmaceuticals | $2.21bn | n/a | n/a |
CGONCG Oncology | $2.18bn | n/a | n/a |
RXRXRecursion Pharmaceuticals | $2.18bn | n/a | n/a |
NVAXNovavax | $2.18bn | n/a | n/a |
KYMRKymera Therapeutics | $2.09bn | n/a | n/a |